Keywords
Pharmaceutical R&D Valuation; Real Options Valuation; Regulatory Risk; Incremental Innovation; CNS Drug Development; Drug Pricing Policy; Market Exclusivity; Monte Carlo Simulation
Materias, derechos, colecciones e identificadores
Pharmaceutical R&D Valuation; Real Options Valuation; Regulatory Risk; Incremental Innovation; CNS Drug Development; Drug Pricing Policy; Market Exclusivity; Monte Carlo Simulation